Open access · CC-BY
via OpenAlex
Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?
Alessandro Castorina, Marta Anna Szychlinska, Rubina Marzagalli, Giuseppe Musumeci
Neural Regeneration Research · 2015 · ▲ 41 citations
Cellular senescence
Stem-cell exhaustion
Stem-cell therapy
Cell culture / in vitro
Human
In vitro
Review
Abstract
Aging is the most prominent risk factor contributing to the development of neurodegenerative disorders. In the United States, over 35 million of elderly people suffer from age-related diseases. Aging impairs the self-repair ability of neuronal cells, which undergo progressive deterioration. Once initiated, this process hampers the already limited regenerative power of the central nervous system, making the search for new therapeutic strategies particularly difficult in elderly affected patients. So far, mesenchymal stem cells have proven to be a viable option to ameliorate certain aspects of neurodegeneration, as they possess high proliferative rate and differentiate in vitro into multiple lineages. However, accumulating data have demonstrated that during long-term culture, mesenchymal stem cells undergo spontaneous transformation. Transformed mesenchymal stem cells show typical features of senescence(definition), including the progressive shortening of telomers, which results in cell loss and, as a consequence, hampered regenerative potential. These evidences, in line with those observed in mesenchymal stem cells isolated from old donors, suggest that senescence may represent a limit to mesenchymal stem cells exploitation in therapy, prompting scholars to either find alternative sources of pluripotent cells or to arrest the age-related transformation. In the present review, we summarize findings from recent literature, and critically discuss some of the major hurdles encountered in the search of appropriate sources of mesenchymal stem cells, as well as benefits arising from their use in neurodegenerative diseases. Finally, we provide some insights that may aid in the development of strategies to arrest or, at least, delay the aging of mesenchymal stem cells to improve their therapeutic potential.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4103/1673-5374.158352
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Castorina, A., Szychlinska, M.A., Marzagalli, R., & Musumeci, G. (2015). Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?. <em>Neural Regeneration Research</em>. https://doi.org/10.4103/1673-5374.158352
Vancouver
Castorina A, Szychlinska MA, Marzagalli R, Musumeci G. Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?. Neural Regeneration Research. 2015. doi:10.4103/1673-5374.158352.
BibTeX
@article{alessandro2015Mesenc,
title = {Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?},
author = {Alessandro Castorina and Marta Anna Szychlinska and Rubina Marzagalli and Giuseppe Musumeci},
journal = {Neural Regeneration Research},
year = {2015},
doi = {10.4103/1673-5374.158352},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
Elsevier eBooks 2009
Citation only
Mesenchymal Stem Cells
Elsevier eBooks 2018
Citation only
Aging of Human Mesenchymal Stem Cells
Tissue Engineering Part B Reviews 2017
Citation only
Mesenchymal Stem Cell-Based Cartilage Regeneration Approach and Cell Senescence: Can We Manipulate Cell Aging and Function?
Biogerontology 2026
Open access · OA
Mesenchymal stem/stromal cell senescence in aging and regenerative medicine: a systematic review.
Journal of Molecular Medicine 2023
Citation only